Santa Clara, Calif.-based Agilent Technologies Inc. (A) provides application-focused solutions for the life sciences, diagnostics, and applied chemicals markets. It has a market value of $33 billion.
Companies valued at $10 billion or more are generally classified as “large-cap stocks,” and A fits the label perfectly, with its market cap exceeding that threshold, indicating its size, influence, and dominance in the diagnostics and research industry. The company specializes in automating complex scientific workflows, integrating high-precision analytical tools such as gas and liquid chromatography with advanced AI-driven informatics to enhance laboratory throughput.
The healthcare company is down 28.3% from its 52-week high of $160.27 on November 25, 2025. A shares have fallen 20% over the past three months, with the S&P 500 index ($SPX) down 1.5% over the same time frame.
Additionally, on a YTD basis, A shares are down 15.6%, compared to the SPX’s marginal decline. In the long term, A has fallen 5.8% over the past 52 weeks, following the SPX’s 20.9% rise over the same time frame.
Confirming its bearish trend, A has been trading below its 200-day moving average since early February and has remained below its 50-day moving average since mid-January.
On February 25, A presented its Q1 results, and its shares fell 3% in the subsequent trading session. The company’s net income increased 7% year-over-year to $1.8 billion, in line with consensus estimates. Meanwhile, adjusted EPS of $1.36 was up 3.8% from last year’s quarter but missed analyst expectations by a penny.
A its competitor, Thermo Fisher Scientific Inc. (TMO) has underperformed, which is down 5.4% over the past 52 weeks and down 14% on a YTD basis.
Despite A’s recent poor performance, analysts are very optimistic about its prospects. The stock has a consensus rating of “Strong Buy” from the 17 analysts that cover it, and an average price target of $165.47 suggests a 42.5% premium to its current price level.
As of the date of publication, Niharika Jain held no positions (either directly or indirectly) in any of the securities mentioned in this article. All information and data in this article are for informational purposes only. This article was originally published on Barchart.com
